Urapidil HCl

Alias: Urapidil hydrochloride; Urapidil HCl
Cat No.:V1025 Purity: ≥98%
Urapidil HCl, the hydrochloride salt of uradipil which is a sympatholytic antihypertensive drug, is potent α1-adrenoceptor antagonist and 5-HT1A receptor agonist with pIC50 of 6.13 and 6.4 respectively.
Urapidil HCl Chemical Structure CAS No.: 64887-14-5
Product category: 5-HT Receptor
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
50mg
100mg
250mg
500mg
1g
2g
5g
10g
Other Sizes

Other Forms of Urapidil HCl:

  • Urapidil
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

Urapidil HCl, the hydrochloride salt of uradipil which is a sympatholytic antihypertensive drug, is potent α1-adrenoceptor antagonist and 5-HT1A receptor agonist with pIC50 of 6.13 and 6.4 respectively. The FDA has not approved urapidil as of yet, but it is accessible in Europe.

Biological Activity I Assay Protocols (From Reference)
Targets
5-HT1A Receptor; α adrenergic receptor; α1-adrenergic receptor ( pIC50 = 6.13 ); α2-adrenergic receptor ( pIC50 = 4.38 )
ln Vitro

In vitro activity: Urapidil hydrochloride is urapidil in hydrochloride salt form, a α1-adrenoceptor antagonist and 5-HT1A receptor agonist with pIC50 values of 6.13 and 6.4, according to the substance. On top of its alpha-blocking effects, urapidil also stimulates serotonin 5HT1A receptors in the central nervous system, which is how it produces its central sympatholytic effect, which sets it apart from other alpha-blockers. On top of its alpha-blocking effects, urapidil also stimulates serotonin 5HT1A receptors in the central nervous system, which is how it produces its central sympatholytic effect, which sets it apart from other alpha-blockers. In patients whose blood pressure is not adequately controlled by other medications, oral urapidil has been shown in multiple studies to be both effective and well-tolerated as a second-line treatment. In hypertensive patients with co-occurring diabetes and/or hyperlipidemia, urapidil has also been demonstrated to enhance glucose and lipid metabolism.

ln Vivo
Urapidil (p.o. or i.v.) results in sedation and decreased tonus in mice and rats[3].
Animal Protocol


References

[1]. Urapidil and some analogues with hypotensive properties show high affinities for 5-hydroxytryptamine (5-HT) binding sites of the 5-HT1A subtype and for alpha 1-adrenoceptor binding sites. Naunyn Schmiedebergs Arch Pharmacol, 1987. 336(6): p. 597-601.

[2]. Urapidil, a dual-acting antihypertensive agent: Current usage considerations. Adv Ther, 2010. 27(7): p. 426-43.

[3]. Neonatal transient respiratory depression after maternal urapidil infusion for hypertension. Eur J Pediatr. 2009 Feb;168(2):221-3.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C20H30CLN5O3
Molecular Weight
423.94
Exact Mass
423.2
Elemental Analysis
C, 56.66; H, 7.13; Cl, 8.36; N, 16.52; O, 11.32
CAS #
64887-14-5
Related CAS #
Urapidil; 34661-75-1
Appearance
Solid powder
SMILES
CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC.Cl
InChi Key
KTMLZVUAXJERAT-UHFFFAOYSA-N
InChi Code
InChI=1S/C20H29N5O3.ClH/c1-22-18(15-19(26)23(2)20(22)27)21-9-6-10-24-11-13-25(14-12-24)16-7-4-5-8-17(16)28-3;/h4-5,7-8,15,21H,6,9-14H2,1-3H3;1H
Chemical Name
6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione;hydrochloride
Synonyms
Urapidil hydrochloride; Urapidil HCl
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: 14.3~24 mg/mL (33.7~56.6 mM)
Water: ~85 mg/mL (~200.5 mM)
Ethanol: <1 mg/mL
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.3588 mL 11.7941 mL 23.5882 mL
5 mM 0.4718 mL 2.3588 mL 4.7176 mL
10 mM 0.2359 mL 1.1794 mL 2.3588 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Clinical Trial Information
NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT03790800 Completed Drug: urapidil Stroke, Acute
Cerebrovascular Disorders
The George Institute for
Global Health, China
March 20, 2020 Phase 3
NCT03497351 Completed Drug: Nicardipine
Drug: Urapidil
General Surgery Chinese PLA General Hospital April 15, 2018 Not Applicable
Biological Data
  • Urapidil HCl
    Effects of intravenous urapidil on (A) SBP, (B) DBP and (C) HR within 7 days of treatment, as compared with nitroglycerin, in elderly patients with hypertension and acute decompensated heart failure.Exp Ther Med. 2016 Jul; 12(1): 115–122.
  • Urapidil HCl
    Effects of intravenous urapidil on the serum level of NT-proBNP within 7 days of treatment, as compared with nitroglycerin, in elderly patients with hypertension and acute decompensated heart failure.Exp Ther Med. 2016 Jul; 12(1): 115–122.
  • Urapidil HCl
    Effects of intravenous urapidil on the (A) LVEF and (B) LVEDV within 7 days of treatment, as compared with nitroglycerin, in elderly patients with hypertension and acute decompensated heart failure.Exp Ther Med. 2016 Jul; 12(1): 115–122.
Contact Us Back to top